Spark Investment Management LLC acquired a new stake in shares of Quanterix Corp (NASDAQ:QTRX) in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 20,100 shares of the company’s stock, valued at approximately $519,000. Spark Investment Management LLC owned 0.09% of Quanterix as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of QTRX. First Republic Investment Management Inc. lifted its holdings in shares of Quanterix by 1.6% in the 1st quarter. First Republic Investment Management Inc. now owns 72,166 shares of the company’s stock worth $1,864,000 after buying an additional 1,135 shares during the period. BNP Paribas Arbitrage SA lifted its holdings in shares of Quanterix by 5,803.2% in the 1st quarter. BNP Paribas Arbitrage SA now owns 1,830 shares of the company’s stock worth $47,000 after buying an additional 1,799 shares during the period. TD Asset Management Inc. lifted its holdings in shares of Quanterix by 4.1% in the 4th quarter. TD Asset Management Inc. now owns 47,700 shares of the company’s stock worth $873,000 after buying an additional 1,900 shares during the period. Jennison Associates LLC lifted its holdings in shares of Quanterix by 1.1% in the 4th quarter. Jennison Associates LLC now owns 297,563 shares of the company’s stock worth $5,448,000 after buying an additional 3,249 shares during the period. Finally, New York State Common Retirement Fund lifted its holdings in shares of Quanterix by 116.7% in the 4th quarter. New York State Common Retirement Fund now owns 6,500 shares of the company’s stock worth $119,000 after buying an additional 3,500 shares during the period. Institutional investors own 51.61% of the company’s stock.
QTRX has been the subject of a number of analyst reports. Zacks Investment Research upgraded Quanterix from a “sell” rating to a “hold” rating in a research note on Thursday, May 9th. Canaccord Genuity restated a “buy” rating and set a $29.00 price objective on shares of Quanterix in a research note on Friday, March 8th.
In other news, Chairman E Kevin Hrusovsky sold 6,817 shares of the stock in a transaction dated Wednesday, April 3rd. The stock was sold at an average price of $24.06, for a total value of $164,017.02. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP David C. Duffy sold 1,277 shares of the stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $20.78, for a total value of $26,536.06. The disclosure for this sale can be found here. Insiders have sold a total of 14,862 shares of company stock worth $351,252 over the last ninety days. 30.80% of the stock is currently owned by corporate insiders.
Shares of NASDAQ QTRX traded down $0.58 during mid-day trading on Friday, reaching $33.48. 119,808 shares of the company were exchanged, compared to its average volume of 115,829. Quanterix Corp has a 1 year low of $13.00 and a 1 year high of $34.32. The stock has a market capitalization of $836.39 million, a P/E ratio of -23.41 and a beta of 0.88. The company has a debt-to-equity ratio of 0.22, a current ratio of 3.10 and a quick ratio of 2.64.
Quanterix (NASDAQ:QTRX) last announced its earnings results on Monday, March 18th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.25) by ($0.17). Quanterix had a negative net margin of 79.48% and a negative return on equity of 76.62%. The business had revenue of $10.88 million for the quarter, compared to analyst estimates of $9.69 million. As a group, equities research analysts anticipate that Quanterix Corp will post -1.56 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This report was first published by Sundance Herald and is the property of of Sundance Herald. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://sundanceherald.com/2019/06/14/20100-shares-in-quanterix-corp-qtrx-acquired-by-spark-investment-management-llc.html.
Quanterix Company Profile
Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.
See Also: Risk Tolerance
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.